Return to search

LeMaitre Vascular

LeMaitre Vascular Inc., a Burlington, Mass.-based developer of medical devices for the treatment of peripheral vascular disease, priced 5.5 million common shares at $7 per share, for an IPO take of approximately $38.5 million. It had planned to sell six million shares at between $8 and $10 per share. LeMaitre will trade on the Nasdaq under ticker symbol LMAT, while Goldman Sachs served as lead underwriter. Housatonic Partners held a 14.3% pre-IPO position.